Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1818503
Max Phase: Preclinical
Molecular Formula: C16H8Cl2F2O2
Molecular Weight: 341.14
Molecule Type: Small molecule
Associated Items:
ID: ALA1818503
Max Phase: Preclinical
Molecular Formula: C16H8Cl2F2O2
Molecular Weight: 341.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1OCC(c2ccc(F)cc2F)=C1c1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C16H8Cl2F2O2/c17-12-4-1-8(5-13(12)18)15-11(7-22-16(15)21)10-3-2-9(19)6-14(10)20/h1-6H,7H2
Standard InChI Key: KQBHIUWSCZITLF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 341.14 | Molecular Weight (Monoisotopic): 339.9869 | AlogP: 4.74 | #Rotatable Bonds: 2 |
Polar Surface Area: 26.30 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.89 | CX Basic pKa: | CX LogP: 5.21 | CX LogD: 5.21 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -0.52 |
1. Borate HB, Sawargave SP, Chavan SP, Chandavarkar MA, Iyer R, Tawte A, Rao D, Deore JV, Kudale AS, Mahajan PS, Kangire GS.. (2011) Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity., 21 (16): [PMID:21757344] [10.1016/j.bmcl.2011.06.022] |
Source(1):